The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Related News Articles

Headline
AHA President and CEO Rick Pollack opened the 2024 AHA Leadership Summit in San Diego discussing the similarities of the U.S. Navy Seals to the hospital field…
Headline
A non-malicious global technology outage that began in the early morning of July 19 is continuing to affect many industries and is having varying effects on…
Headline
John Riggi, AHA’s national advisor for cybersecurity and risk, participated July 18 as the opening keynote speaker in the Information Security Media Group’s…
Headline
A joint advisory issued the week of July 8 by the Cybersecurity and Infrastructure Security Agency, National Security Agency, FBI and several international…
Headline
The AHA July 2 submitted comments to the Cybersecurity and Infrastructure Security Agency on its proposed rule establishing reporting requirements for…
Headline
The Department of Health and Human Services Health Sector Cybersecurity Coordination Center June 27 issued an alert about a critical vulnerability in MOVEit, a…